Benzenesulfonamide

Benzenesulfonamide

SCHEMBL6885520

CN1CCN(C2CCC(n3cc(-c4ccc(NS(=O)(=O)c5ccc(Cl)s5)c(F)c4)c4c(N)ncnc43)CC2)CC1.NS(=O)(=O)c1ccccc1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEK Q02763 3/20 0.65
▸ EIF2AK3 Q9NZJ5 5/20 0.53
▸ EGFR P00533 2/20 0.52
▸ ERBB2 P04626 2/20 0.52
▸ ERBB4 Q15303 2/20 0.52
▸ IGF1R P08069 1/20 0.52
▸ ERBB3 P21860 1/20 0.52
▸ LCK P06239 2/20 0.51
▸ SRC P12931 2/20 0.51
▸ HCK P08631 2/20 0.51
▸ PLK4 O00444 1/20 0.51
▸ DCLK1 O15075 1/20 0.51
▸ PDPK1 O15530 1/20 0.51
▸ PRKD3 O94806 1/20 0.51
▸ MAP4K4 O95819 1/20 0.51
▸ PAK4 O96013 1/20 0.51
▸ CHEK2 O96017 1/20 0.51
▸ ABL1 P00519 1/20 0.51
▸ NTRK1 P04629 1/20 0.51
▸ INSR P06213 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6878984 0.94 TEK (0.62) TEKEIF2AK3EGFRERBB2ERBB4
Benzenesulfonamide SCHEMBL6459329 0.88 TEK (0.65) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6878546 0.87 EIF2AK3 (0.68) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6876636 0.84 TEK (0.60) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6460184 0.84 TEK (0.67) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6465261 0.83 TEK (0.66) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6459888 0.83 TEK (0.72) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6462812 0.83 TEK (0.70) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6462087 0.83 TEK (0.67) TEKEIF2AK3EGFRERBB2ERBB4
SCHEMBL6464132 0.83 TEK (0.67) TEKEIF2AK3EGFRERBB2ERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004100868-A2 METHOD OF TREATING TRANSPLANT REJECTION ABBOTT LABORATORIES (US) 2004-11-25 — — WO disclosed
Send feedback